Your browser doesn't support javascript.
loading
Dose escalation phase 1 study of radiotherapy in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 monoclonal antibody ipilimumab in patients with metastatic melanoma.
Boutros, Celine; Chaput-Gras, Nathalie; Lanoy, Emilie; Larive, Alicia; Mateus, Christine; Routier, Emilie; Sun, Roger; Tao, Yun Gan; Massard, Christophe; Bahleda, Rastilav; Schwob, Dominique; Ibrahim, Nathalie; Khoury Abboud, Rita Maria; Caramella, Caroline; Lancia, Andrea; Cassard, Lydie; Roy, Severine; Soria, J-C; Robert, Caroline; Deutsch, Eric.
Afiliación
  • Boutros C; Dermatology Unit, Outpatient Clinic, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Chaput-Gras N; Laboratoire d'immunomonitoring En Oncologie, University Paris-Saclay, Faculty of Pharmacy, Gustave Roussy Cancer Campus, Villejuif, France.
  • Lanoy E; Biostatistic and Epidemiology Unit, Gustave Roussy Cancer Campus, Villejuif, France.
  • Larive A; Biostatistic and Epidemiology Unit, Gustave Roussy Cancer Campus, Villejuif, France.
  • Mateus C; Dermatology Unit, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, UK.
  • Routier E; Dermatology Unit, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, UK.
  • Sun R; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Tao YG; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Massard C; DITEP, University Paris-Saclay, Faculty of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Bahleda R; DITEP, University Paris-Saclay, Faculty of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Schwob D; Biostatistic and Epidemiology Unit, Gustave Roussy Cancer Campus, Villejuif, France.
  • Ibrahim N; Outpatient Clinic, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Khoury Abboud RM; Outpatient Clinic, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Caramella C; Department of Radiology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Lancia A; Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Cassard L; Radiation Oncology, Polyclinic San Matteo Pavia Fondazione IRCCS, Pavia, Italy.
  • Roy S; Laboratoire d'immunomonitoring En Oncologie, University Paris-Saclay, Faculty of Pharmacy, Gustave Roussy Cancer Campus, Villejuif, France.
  • Soria JC; Dermatology Unit, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, UK.
  • Robert C; DITEP, INSERM Unit U981, University Paris-Saclay, Faculty of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
  • Deutsch E; Dermatology Unit, Department of Medicine, University Paris-Saclay, Faculty of Medicine, INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France.
J Immunother Cancer ; 8(2)2020 08.
Article en En | MEDLINE | ID: mdl-32819972
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno CTLA-4 / Ipilimumab / Melanoma Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Antígeno CTLA-4 / Ipilimumab / Melanoma Tipo de estudio: Risk_factors_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: J Immunother Cancer Año: 2020 Tipo del documento: Article País de afiliación: Francia